Akzo Nobel Spins Off Pharma Unit

Avatar for Matt Hopkins By Scott C. Lucas|20 September 2006

The new dedicated pharma firm will be called Organon Biosciences. It will include human pharmaceuticals, veterinary products, fine chemicals synthesis operations, and vaccines. These operations had combined sales in 2005 of US $4.4 billion, 27% of Akzo Nobel’s total sales of US $16.2 billion.

A major strategic review of chemicals over the past 18 months has trimmed the company’s business to five major areas. The five are pulp and paper chemicals; polymer chemicals, primarily organic peroxides; industrial and specialty surfactants; functional specialty chemicals; and base chemicals.

Hide picture